Exploring Cancer Immunotherapy for the Future


Welcome to Noile-Immune Biotech


Noile-Immune Biotech is a clinical stage biotechnology company focused on the development and commercialization of novel cancer immunotherapy products utilizing the immune system to eradicate cancer cells. 

Our goal is to discover and develop innovative cancer immunotherapies through partnerships with experts in academia including National Cancer Center (NCC) in Japan. 

Noile-Immune Biotech was founded in April 2015, and is located in Tokyo, Japan.